ArticleBMC gastroenterology2026
Diagnostic value of CT-quantified abdominal fat parameters for metabolic dysfunction-associated fatty liver disease.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo analyze the diagnostic value of CT-derived abdominal fat indices in predicting MAFLD and establish an integrated diagnostic system.
methodsA retrospective study on 174 patients with a previous history of abdominal CT examination in our institute between January 2022 and June 2024 was conducted, comprising 120 diagnosed with MAFLD, and 54 controls without it. CT-derived measures including SAT, visceral adipose tissue volume(VAT), total liver volume, and average hepatic. The average value and CT attenuation value of the left and right lobe of liver and the VAT/SAT were compared using Mann-Whitney U test. were compared between both groups. Then, we used Spearman's rank correlation analysis to study whether there existed correlations between CT metrics and metabolic indicators. Logistic regression and receiver operating characteristic(ROC)curve analysis were utilized to evaluate the diagnostic accuracy of individual parameters.Calibration of a composite prediction model was evaluated by using calibration plots.
resultsIn MAFLD groups, SAT, VAT, liver volume, and the VAT / SAT ratio were higher than those of the control group, while the mean hepatic CT attenuation value, as well as the mean attenuation value of the left lobe and right lobe, were all lower than those of the control group (all P < 0.05). The mean hepatic CT attenuation correlated negatively with BMI (r = -0.607) and TG (r = -0.418), while the sign was positive for VAT. In univariate logistic regression, we found that the mean hepatic CT attenuation is the best diagnostic indicator of MAFLD, with an AUC of 0.923, then were left and right hepatic attenuation (AUC = 0.886), liver volume (AUC = 0.814), and VAT's mean CT attenuation (AUC = 0.796). BMI (r = 0.554) and UA (r = 0.362) were also considered. Combining SAT, VAT, and mean hepatic CT attenuation together in one model resulted in an AUC of 0.928 (sensitivity: 91.7%, specificity: 85.2%). The calibration curves demonstrated an acceptable fit of the model. When multiple variables were combined, the sensitivity improved from 85.8% to 91.7% and specificity changed from 87.0% to 85.2%, yielding an AUC of 0.928 (ΔAUC = 0.005 compared with mean hepatic CT attenuation alone, P = 0.62).
conclusionCT-measured abdominal fat may represent a reliable and noninvasive approach for the diagnosis of MAFLD.The greatest individual diagnostic utility was exhibited by mean liver CT attenuation alone; however, with multiple variables merged into a combined model, the sensitivity and specificity were also further increased, which could be an effective method to image MAFLD in clinical diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.